Universitärer Forschungscluster „Sustainable Technologies in Metal Production and Processing” (STMP)

Foundation of a university research cluster — Co-operation along the value creation chain from raw materials to components — Evidence of joint performance offers — Utilization of synergies — Integration of Christian Doppler Laboratories — Flexible arrangement of co-operations and networks     

US Army Reliability Initiatives?In Concert with Air Force R&M 2000

This paper describes how the US Army is improving readiness through enhanced reliability, availability, and maintainability (RAM). The Army is serious about supplying its personnel with the kind of equipment that stays on line. The US Army Materiel Command is taking aggressive steps to ensure that systems achieve their RAM requirements. Too often the Army has been accused of settling for minimum performance. As is well known, industry is reactive; it responds to pressure to improve what the customer thinks is important. An important step to getting higher levels of reliability and maintainability is to stand together with the Air Force and Navy customers and demand that RAM design and manufacturing disciplines are carried out and contractual RAM requirements are achieved. The achievement of requirements must be accomplished during system development and fielding. Improved RAM results in improved productivity, user satisfaction, and lower operating and support (O&S) costs. Linking R&M initiatives with O&S cost is an important step in justifying the up-front design and manufacturing disciplines that improve field performance. Meeting RAM requirements is the beginning and not the end of Army reliability efforts. Continued efforts to improve RAM are the thrust. For each system, the Army strives for continued improvement. Increased reliability reduces O&S costs while improving fielded mission accomplishment. Contractors will continue their efforts to improve production quality and to eliminate systemic causes of field failures.     

Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients

Our objective was to determine the maximum tolerated dose of cyclosporin A (CsA) delivered as a loading dose (LD) and continuous i.v. infusion (CI) in combination with carboplatin in patients with refractory gynecologic cancers. Twenty-nine heavily pretreated patients (25 ovarian epithelial, 2 cervical, and 2 endometrial carcinomas) received 113 cycles of CsA and carboplatin from September 1989 to September 1991. Twenty-four of these 29 carcinomas were strictly defined to be platinum resistant. CsA was administered as a LD escalated from 6 to 10 mg/kg followed by a 24-h CI from 2.5 to 14.5 mg/kg/day. Carboplatin was targeted to an area under the time versus concentration curve (AUC) of 6 mg/ml x min and was not dose escalated. Whole-blood CsA concentrations (fluorescence polarization immunoassay) at the maximum tolerated dose (10 mg/kg LD, 14.5 mg/kg/day CI) ranged from 2.4 to 3.0 microgram/ml over 12 h. Estimated median carboplatin AUC, based on calculated carboplatin clearance, was 7.9 mg/ml x min. The dose-limiting toxicity of the combination of CsA and carboplatin was grade 4 thrombocytopenia. Grade 3 or 4 thrombocytopenia occurred in 35% of the patients, which could be explained by the effects of carboplatin (AUC of 6 mg/ml x min) alone. Overall, neutropenia occurred in 24% of the patients and anemia in 17% of the patients. Grade 3 or 4 nausea or vomiting was noted in 10 and 14% of the patients, respectively. Grade 3 hypertension during CsA administration occurred in 14% of the patients. No grade 3 or 4 nephrotoxicity was seen in this trial. Three objective responses were noted: one complete response (11 months) and one partial response (5 months), both in potentially platinum-sensitive patients with platinum-free intervals of only 9 months each. One platinum-resistant patient had a partial response for 21 months. Five additional patients experienced >75% reduction of CA-125 or a return to a normal CA-125 titer. We concluded that whole-blood CsA concentrations of >3.0 microgram/ml (as seen when CsA is used as a modulator of multidrug resistance) were not achievable in this combination with carboplatin in this population of heavily pretreated gynecologic cancer patients. However, because CsA is used in this trial as a chemosensitizer in platinum-sensitive tumors and as a chemomodulator of platinum resistance, we targeted a CsA concentration of >1.0 microgram/ml, which was achieved. The CsA dose recommended for a Phase II trial of this combination is 10 mg/kg LD and 11.6 mg/kg/day CI, which results in blood CsA concentrations ranging from 1.2 to 1.3 microgram/ml over 12 h. Responses in this population of refractory gynecologic cancer patients are unusual, and these encouraging results form the basis for a Phase II trial of this combination.     

Phenformin-associated lactic acidosis due to imported phenformin

OBJECTIVE: To emphasize the continued incidence of phenformin-associated lactic acidosis. CASE REPORT: We report a case of phenformin-associated lactic acidosis in a Chinese man who received phenformin while in China. Diagnosis was made; the patient was treated appropriately and survived. COMMENTS: Phenformin-associated lactic acidosis may still occur in the U.S.     

Basement membranes of small cardiac vessels in patients with diabetes and myxoedema: preliminary observations

A method of treating completely displaced supracondylar fractures of the humerus in children by 'straight lateral traction', as originally used by John Dunlop, is recommended. The results in 26 children, selected because manipulation had failed to achieve reduction, is examined, and indicates that this treatment is satisfactory for some problem fractures, leading usually to good results in terms of resolution of complications and return of function. It also avoids the ugly deformities of the elbow which follow reliance on a single form of treatment for all supracondylar fractures. Failure of anatomical reduction by the appliance is shown to be in the plane of elbow movement, where normal physiological mechanisms correct the bone by remodelling. Where there is epiphyseal damage, deformities may occur with any form of treatment.     

Use and effectiveness of hypothermia blankets for febrile patients in the intensive care unit

We performed a prospective observational (noninterventional) study of hypothermia blanket use in a population of adult intensive care unit patients with body temperatures of > or = 102.5 degrees F. Thirty-nine of ninety-four febrile episodes (in 83 patients) were treated with hypothermia blankets. Logistic regression revealed that the strongest independent predictors of hypothermia blanket use were a temperature of > or = 103.5 degrees F (odds ratio [OR] = 17), mechanical ventilation (OR = 25), and acute central nervous system illness (OR = 7.5). Hospitalization in the medical intensive care unit was strongly associated with avoidance of this therapy (OR = 0.023). Treatment with a hypothermia blanket was ordered by a physician in only 15% of cases. The mean cooling rate was the same (0.028 degree F/h) for blanket-treated and control patients. Multivariate Cox regression and factorial and repeated measures of analysis of variance revealed that blanket treatment was not more effective than other cooling methods. However, this treatment was associated with more "zigzag" temperature fluctuations of > or = 3 degrees F (56% of blanket-treated patients vs. 18% of control patients; P < .001) and rebound hypothermia (18% vs. 0; P = .001). Hypothermia blanket therapy is primarily a nursing decision. We conclude that in addition to being no more effective than other cooling measures, hypothermia blanket therapy was associated with more temperature fluctuations and with more episodes of rebound hypothermia.     

Bounded determinization of timed automata with silent transitions

Deterministic timed automata are strictly less expressive than their non-deterministic counterparts, which are again less expressive than those with silent transitions. As a consequence, timed automata are in general non-determinizable. This is unfortunate since deterministic automata play a major role in model-based testing, observability and implementability. However, by bounding the length of the traces in the automaton, effective determinization becomes possible. We propose a novel procedure for bounded determinization of timed automata. The procedure unfolds the automata to bounded trees, removes all silent transitions and determinizes via disjunction of guards. The proposed algorithms are optimized to the bounded setting and thus are more efficient and can handle a larger class of timed automata than the general algorithms. We show how to apply the approach in a fault-based test-case generation method, called model-based mutation testing, that was previously restricted to deterministic timed automata. The approach is implemented in a prototype tool and evaluated on several scientific examples and one industrial case study. To our best knowledge, this is the first implementation of this type of procedure for timed automata.     

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

BACKGROUND: Posttransplant lymphoproliferative disorder (PTLD) has been observed with increasing frequency consequent to the availability of more effective and potent immunosuppression. Prior work suggested that a peripheral blood monitoring strategy detecting peripheral B lymphoproliferation was effective in the early diagnosis of PTLD among 7 of 179 (3.9%) consecutive transplant recipients. Each of those seven patients received at least one course of antithymocyte globulin, Minnesota antilymphocyte globulin, or OKT3 before developing PTLD. METHODS: To determine whether antiviral prophylaxis might reduce the incidence of PTLD, a subsequent group of 198 consecutive recipients received either ganciclovir or acyclovir during antilymphocyte antibody administration. When the donor or recipient were cytomegalovirus-seropositive, ganciclovir was given; acyclovir was used when both were cytomegalovirus-seronegative. Baseline and protocol posttransplant cell surface profiles were obtained using immunofluorescence and flow cytometry to detect T cells, lymphocyte activation markers, and the CD19 B cell antigen. RESULTS: Demographic factors, including the incidence of recipients more than 50 years of age, non-Caucasians, previous transplantation, and diabetes mellitus, were similar in both groups. Additionally, the number of patients receiving antilymphocyte preparations was similar. However, only one patient (0.5%) from the latter group who received preemptive antiviral therapy developed PTLD. Although elevations in CD19+ B cells preceded clinical PTLD among each of the seven earlier patients, evidence of peripheral B cell proliferation was not demonstrated for the sole patient from the latter group, which suggests a possible effect of antiviral therapy. CONCLUSIONS: Prophylactic antiviral therapy may reduce the sensitivity of peripheral monitoring for B lymphoproliferation, but the dramatic reduction in PTLD incidence strongly supports its use among transplant recipients at risk.     

Can minimally trained observers provide valid global ratings?

From a cost-benefit perspective, the validity of minimally trained (MT) coders' ratings was examined individually and relative to ratings by coders who had undergone "gold standard" (GS) training in the rating of maternal overreactive discipline. The ratings of MT and GS coders were strongly associated (r = .72). MT ratings were also correlated with maternal self-reported overreactive discipline (r = .39), laxness (r = .46), depressive symptoms (r = .32), and observed child misbehavior (r = .40). These correlations were of similar magnitude to correlations based on GS ratings. MT ratings were more strongly associated with GS ratings than with child misbehavior. Thus, their ratings demonstrated convergent, concurrent, and discriminant validity. Implications and limitations of these findings are discussed. (PsycINFO Database Record (c) 2011 APA, all rights reserved)     

Relationships between dioxins in soil, air, ash, and emissions from a municipal solid waste incinerator emitting large amounts of dioxins

The Columbus Municipal Waste-to-Energy (Columbus WTE) facility in Columbus, Ohio, began operation in June, 1983 and ceased operation in December, 1994. During its operation, it was estimated to have released nearly 1,000 grams of dioxin Toxic Equivalents (TEQs) per year. This compares to a 1994 estimate of 9,300 g TEQ/yr from all sources emitting dioxins into the air in the United States (EPA, 1994), and to total releases of dioxins near or below 1,000 grams TEQ/Yr for England (Eduljee and Keyke, 1996), Belgium (Wevers and De Fre, 1995), and West Germany (Fiedler and Hutzinger, 1992). Because of the magnitude of emissions from this single source, studies were undertaken to evaluate the impacts to air and soil near the incinerator. This paper presents analyses evaluating dioxin concentrations and profiles in four media: stack gas, ambient air within 3 km of the incinerator, soil samples up to 8 km from the incinerator, and incinerator ash. Principal findings include: 1) an "incinerator signature" profile, as defined by stack gas emissions, was found in the ash and in subsets of the air and soil matrices, 2) soil concentrations declined from directly outside the incinerator property to the city at large, 3) an urban background soil concentration of dioxin Toxic Equivalents (TEQs) was estimated at 4 pg/g, while concentrations generally within 2 km of the incinerator ranged from 4-60 pg TEQ/g, 4) an urban background air concentration was estimated at 0.05 pg TEQ/m3, while air concentrations at a specific location about 2 km in the downwind direction of the incinerator had concentrations of 0.17 and 0.35 pg TEQ/m3 during two sampling dates, 5) analysis of the soil monitoring data in combination with the stack test data suggests that less than 2% of emitted dioxins can be found in the soil near the incinerator, and 6) principal component analysis suggests that the fraction of total concentration of OCDD is the single feature explaining most of the variation of all concentration profiles. This paper discusses these and other findings, and their implications.